Related Experiment Videos
False-negative results in screening programmes: systematic review of impact and implications
M P Petticrew1, A J Sowden, D Lister-Sharp
1Hester Adrian Research Centre, University of Manchester, UK.
Health Technology Assessment (Winchester, England)
|June 20, 2000
Summary
False-negative results in screening programmes can delay cancer detection and lead to legal action. While evidence is limited, these inaccurate results may negatively impact public trust in healthcare screening services.
Area of Science:
- Public Health
- Medical Screening
- Health Services Research
Background:
- Screening programmes must balance benefits against harms, including false-negative results.
- False-negatives can lead to diagnostic delays and false reassurance.
- No screening test is 100% accurate; false-negatives are an inherent limitation.
Purpose of the Study:
- To determine the consequences of false-negative findings in national screening programmes.
- To investigate methods for minimizing adverse effects of false-negatives.
- To assess implications for the National Health Service (NHS) and public confidence.
Main Methods:
- Systematic literature review of 18 electronic databases, bibliographies, and expert contacts.
- Outcomes assessed included medical, psychological, economic, and legal consequences.
- Included analysis of impact on public confidence in screening programmes.
Main Results:
- Limited quantitative data on medical and psychological consequences; anecdotal evidence prevalent.
- One study linked false-negatives in antenatal screening to lower parental acceptance.
- Evidence suggests significant legal impact (e.g., cervical screening litigation) and potential negative impact on public confidence, though evidence is limited.
Conclusions:
- False-negatives occur even in high-quality screening programmes.
- Potential for delayed cancer detection (breast, cervical); psychological consequences poorly understood.
- False-negatives are likely to result in legal action and may reduce public confidence in screening.